Senior insider sale
Chief Medical Officer at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$953.6K
1.89K shares
What this filing means
SOERGEL DAVID plans to sell 1.89K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $953.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001950047-26-005407
Officer· Chief Medical Officer
Since Mar 2026
1.89K
Shares to sell
$953.6K
Approx. market value
1.04K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/15/2026
1.04KTotal acquired1.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Units N/A | 1.04K | — |
| Total | 1.04K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
844.00
Market value
$435.4K
5/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.04K
Market value
$518.2K
6/1/2026
Total
Units
1.89K
Value
$953.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/18/2026 | 844.00 | $435.4K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 1.04K | $518.2K | NASDAQ | Planned |
| Total | 1.89K | $953.6K | ||